Rezolute CFO Evans Makes a Strategic Investment: Buys Shares Worth $79,577
Rezolute CFO Evans Makes a Strategic Investment: Buys Shares Worth $79,577 Read Post »
Introduction to Rezolute and Its Financial Landscape Rezolute, Inc. is a biopharmaceutical company dedicated to transforming the lives of patients suffering from serious health conditions through the development of innovative therapies. Founded with the mission to advance transformative treatments, Rezolute is particularly focused on creating solutions for ailments such as diabetes and rare metabolic disorders.
